We are your partner in biosimilars and breakthrough therapies. With our support, you can ensure your patients benefit from the latest advances in this field while at the same time keeping healthcare costs under control.
Researchers, manufacturers and investors
We are always on the lookout for promising new molecules. With our in-house medical expertise and extensive local contacts, we can onboard new products quickly and efficiently, and facilitate sales and distribution in Switzerland and other European countries.
Swiss pharma experts
We help you access the Swiss ecosystem.
End-to-end relationship
We provide full support, from market studies to distribution agreements.
About iQone
.webp?width=2000&name=Portrait-iQone%20(1).webp)
With opportunity comes responsibility. iQone was founded in 2013 by a handful of experts from leading pharmaceutical companies who recognized the disruptive potential of biosimilars. They came up with an agile model to promote these and other life-changing drugs in Switzerland, serving as the crucial link between global manufacturers and local healthcare professionals. iQone's unique combination of social responsibility, expertise and personalized service helps to improve the lives of countless patients.
Products and pipeline

iQone has one of the most complete biosimilar portfolios in Switzerland and we are steadily diversifying with innovative new drugs. We specialize in oncology and immunology in general, with a particular focus on rheumatology, gastro-enterology and onco-haematology, yet we are poised to expand into other disease areas. We source our products from leading developers of pharmaceuticals and biologics around the world.
Our services for healthcare professionals
.webp)

Partners
The relationships we build with our partners are essential to our success. Our solid and mutually beneficial collaboration ensures that the advances achieved by researchers and manufacturers alike reach their target markets.

Working at iQone
Ready for a change of pace? We offer experienced professionals the opportunity to make a real difference in a fast-growing company.

What our partners say about us
Don't just take our word for it! Here's what some of our stakeholders have to say about us.

“We value our open and constructive collaboration with iQone. Our combined success is a result of their intimate knowledge of the Swiss pharmaceutical ecosystem, their connections and their efficient, expert team.”

“I’m very satisfied with iQone’s service, and especially with how their team solves any problems that arise. They’re always very easy for me to reach, and they help me quickly and unbureaucratically.”

“We support our partners in delivering excellent services to our customers. The straightforward exchange of information and trust that we share with iQone is the optimal basis for our collaboration. With this spirit we perform at our best every day and continue to explore new solutions.”
iQone joining the Celltrion group FAQs
Why is iQone joining the Celltrion group?
This integration is the fruit of a solid partnership that has lasted for more than ten years. By joining the Celltrion Group, a world leader in biosimilars, iQone benefits from increased resources, enabling it to develop its product portfolio and improve access to treatment by supporting healthcare professionals in delivering quality care in Switzerland.
Will the iQone name change?
No, the iQone company name will remain unchanged. We will continue to offer the same service and guarantee the quality you know under the ‘iQone’ brand.
Will this affect the products you offer?
No, our current products and their brand names will remain unchanged. You can continue to benefit from the biosimilar medicines you are already using, with the same quality.
Will anything change in the way we work with you?
No, we will continue to offer the same customised service that you already enjoy under the name ‘iQone for You’. All existing collaborations and contracts will continue unchanged. The purpose of this acquisition is to strengthen our innovation and service capabilities to better meet your needs and those of your patients, but it will in no way disrupt the relationship we have built together.
Will iQone be changing location or staff?
How will this integration affect customer service?
Customer service will remain exactly the same. We will continue to offer a high-quality, personalised service, and to listen to your every need.
Will current contracts change?
No changes will be made to existing contracts. All existing commitments will continue unchanged, and we look forward to continuing our partnerships.
What happens if I have questions or concerns about this change?
If you have any questions or concerns, please do not hesitate to contact us. You can contact our support team on +41 22 510 29 30 for any further information. We look forward to working with you!
Does the ordering process remain the same or do I have to contact someone else to order?
All the telephone numbers and email addresses for ordering remain the same. You can place your orders here: iqone@avosano.ch or call us on +41 58 230 33 70